Clinical Practice Guidelines (CPG) on EBMonFHIR
1.0.2 - ci-build

Clinical Practice Guidelines (CPG) on EBMonFHIR, published by Universitätsmedizin Greifswald. This guide is not an authorized publication; it is the continuous build for version 1.0.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/CEOsys/cpg-on-ebm-on-fhir/ and changes regularly. See the Directory of published versions

: COVID19 Intensive Care Treatment Guideline - XML Representation

Raw xml | Download


<Composition xmlns="http://hl7.org/fhir">
  <id value="COVID19IntensiveCareTreatmentGuideline"/>
  <meta>
    <profile
             value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/guideline"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Composition COVID19IntensiveCareTreatmentGuideline</b></p><a name="COVID19IntensiveCareTreatmentGuideline"> </a><a name="hcCOVID19IntensiveCareTreatmentGuideline"> </a><a name="COVID19IntensiveCareTreatmentGuideline-en-US"> </a><p><b>identifier</b>: Resource identifier/113-001</p><p><b>version</b>: 7.0</p><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:{https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system clinical-practice-guideline}, {https://data.cochrane.org/concepts/ e07eN1w1Rwswg4}">Guidelines</span></p><p><b>category</b>: <span title="Codes:{https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-guideline-stage-classification S3}">Evidence- and consensus-based guideline</span></p><p><b>date</b>: 2022-03-01</p><p><b>author</b>: <a href="Organization-AWMFOrganization.html">Organization Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) e.V.</a></p><p><b>title</b>: Empfehlungen zur stationären Therapie von Patienten mit COVID-19 - Living Guideline</p><h3>RelatesTos</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style="display: none">*</td><td>Citation</td><td><a href="Citation-COVID19IntensiveCareTreatmentGuidelineCitation.html">Citation COVID19_Intensive_Care_Treatment_Guideline</a></td></tr></table></div>
  </text>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="RI"/>
        <display value="Resource identifier"/>
      </coding>
    </type>
    <system value="https://www.awmf.org/"/>
    <value value="113-001"/>
  </identifier>
  <version value="7.0"/>
  <status value="final"/>
  <type>
    <coding>
      <system
              value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system"/>
      <code value="clinical-practice-guideline"/>
    </coding>
    <coding>
      <system value="https://data.cochrane.org/concepts/"/>
      <code value="e07eN1w1Rwswg4"/>
      <display value="Guidelines"/>
    </coding>
  </type>
  <category>
    <coding>
      <system
              value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-guideline-stage-classification"/>
      <code value="S3"/>
      <display value="Evidence- and consensus-based guideline"/>
    </coding>
  </category>
  <date value="2022-03-01"/>
  <author>🔗 
    <reference value="Organization/AWMFOrganization"/>
  </author>
  <title
         value="Empfehlungen zur stationären Therapie von Patienten mit COVID-19 - Living Guideline"/>
  <relatesTo>
    <type value="citation"/>
    <resourceReference>🔗 
      <reference
                 value="Citation/COVID19IntensiveCareTreatmentGuidelineCitation"/>
    </resourceReference>
  </relatesTo>
  <section>
    <title value="Stationäre Therapie von COVID-19 Patienten"/>
    <code>
      <coding>
        <system
                value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system"/>
        <code value="guideline-recommendation"/>
        <display value="Clinical practice guideline recommendation"/>
      </coding>
    </code>
    <focus>🔗 
      <reference
                 value="PlanDefinition/COVID19VentilatedPatientsDexamethasoneApplicationPlan"/>
    </focus>
    <text>
      <status value="generated"/>
      <div xmlns="http://www.w3.org/1999/xhtml"><strong>Systemische Steroide:</strong> Bei Patienten mit COVID-19- und Sauerstoff-Bedarf (Niedrigfluss-Sauerstoff-Insufflation, High-Flow Nasal Cannula, Nichtinvasive Beatmung/CPAP, invasive Beatmung) soll eine Therapie mit systemischen Kortikosteroiden erfolgen. Die Therapie sollte mit 6 mg Dexamethason p.o. oder i.v. über zehn Tage erfolgen.</div>
    </text>
  </section>
  <section>
    <title value="Stationäre Therapie von COVID-19 Patienten"/>
    <code>
      <coding>
        <system
                value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/ceosys-code-system"/>
        <code value="guideline-recommendation"/>
        <display value="Clinical practice guideline recommendation"/>
      </coding>
    </code>
    <focus>🔗 
      <reference
                 value="PlanDefinition/COVID19NonVentilatedPatientsDexamethasoneApplicationPlan"/>
    </focus>
    <text>
      <status value="generated"/>
      <div xmlns="http://www.w3.org/1999/xhtml"><strong>Systemische Steroide:</strong> Bei Patienten mit moderater Erkrankung (hospitalisiert ohne Notwendigkeit von Niedrigfluss-Sauerstoff-Insufflation) soll keine Therapie mit systemischen Kortikosteroiden erfolgen.</div>
    </text>
  </section>
</Composition>